Product | Human PON2 |
Cat# | 101-5-04A |
Sequence | His-Tag sequence not included: MGRLVAVGLL GIALALLGER LLALRNRLKA SREVESVDLP HCHLIKGIEA GSEDIDILPN GLAFFSVGLK FPGLHSFAPD KPGGILMMDL KEEKPRAREL RISRGFDLAS FNPHGISTFI DNDDTVYLFV VNHPEFKNTV EIFKFEEAEN SLLHLKTVKH ELLPSVNDIT AVGPAHFYAT NDHYFSDPFL KYLETYLNLH WANVVYYSPN EVKVVAEGFD SANGINISPD DKYIYVADIL AHEIHVLEKH TNMNLTQLKV LELDTLVDNL SIDPSSGDIW VGCHPNGQKL FVYDPNNPPS SEVLRIQNIL SEKPTVTTVY ANNGSVLQGS SVASVYDGKL LIGTLYHRAL YCEL |
Unit/Weight | 0.01 mg |
Unit Price | $228.00 |
Description | Paraoxonase 2 (PON2) is a member of a multigene family whose genes share 65% identity at the amino acid level, and is expressed in a variety of tissues, including the pancreas. PON2 overexpression has been shown to lower the intracellular oxidative state and reduce the cell’s ability to oxidize LDL. PON2 is therefore implicated in the modulation of oxidative stress. Recombinant human PON2 is expressed in E. coli with an amino-terminal hexahistidine tag. |
Molecular Weight | 43.51 kDa |
Purity | Purity > 95% as determined by reducing and non-reducing SDS-PAGE, Bradford assay, Western blot and ELISA |
Storage | Store at -20°C. Product is guaranteed one year from the date of shipment. |
Peptide synthesis/Peptide Library Synthesis/Peptide Modification/Antibody Preparation Eve He eve@pepmic.com www.pepmic.com
2018年12月27日星期四
Human PON2
订阅:
博文评论 (Atom)
没有评论:
发表评论